Novavax Inc
(WBO:NVAX)
€
9.276
-0.09 (-0.96%)
Market Cap: 1.49 Bil
Enterprise Value: 734.28 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 47/100 Novavax Inc at Bank of America Global Healthcare Conference Transcript
May 11, 2023 / 05:00PM GMT
Alec Warren Stranahan
BofA Securities, Research Division - Associate
Hello Everyone, good afternoon, and welcome to -- or I guess, good morning. Welcome to day 3 of the 2023 BofA Healthcare Conference. Thanks for joining the session with Novavax. My name is Alec Stranahan. I'm Vice President and senior biotech analyst covering Novavax at BofA. And I'm pleased to be joined by John Jacobs, President and Chief Executive Officer of Novavax, as well as Filip Dubovsky, Executive Vice President and Chief Medical Officer.
Thanks for being here, guys.
John Charles Jacobs
Novavax, Inc. - President, CEO & Director
Our pleasure. And thanks to those of you who joined us live as well. This is one of the last sessions of the conference. I appreciate you being here.
Alec Warren Stranahan
BofA Securities, Research Division - Associate
Saving the best for last.
Questions & Answers
Alec Warren Stranahan
BofA Securities, Research Division - Associate
Yes. So let
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot